B) At the end of follow-up (median 37 months, n = 315).
| Sensitivity | Specificity | PPV | NPV | Diagnostic accuracy | |
|---|---|---|---|---|---|
| ATA | 80,4 | 46,5 | 20,4 | 93,3 | 51,4 |
| ETA | 73,9 | 60,6 | 24,3 | 93,1 | 62,5 |
| ATA after SPECT/CT | 78,3 | 72,9 | 33,0 | 95,1 | 73,7 |
| SPECT/CT | 71,7 | 86,6** | 47,8 | 94,7 | 84,4*** |
| Risk at 1 year | 100* | 93,3** | 71,9 | 100 | 94,3*** |
*No significant differences in sensitivities were found except in case of one-year reclassification (p < 0.01).
**Specificities of the individual parameters differed significantly, the one-year reclassification had the highest value (p < 0.01). The specificity of SPECT/CT was also significantly better than the values of the ATA and ETA risk classifications (p < 0.001).
***Diagnostic accuracy of one-year reclassification was excellent but not significantly better than that of SPECT/CT (p = 0.59). Both method provided better prediction than ATA, ETA and ATA after SPECT/CT classifications (p < 0.01).